Digirad Corporation Stock Price and Value Analysis

Should you buy Digirad Corporation stock? (NasdaqGM:DRAD). Let's see how it does in our automated value investing analysis system.

DRAD Free Cash Flow Trend

Free Cash Flow trendline for DRAD
Free Cash Flow trendline for Digirad Corporation

Hmm, we can't give any reliable projection for Digirad Corporation's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantages
  • This company has a large dividend yield!
  • This company is not making money.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This stock looks overpriced.

Inside the DRAD Numbers

DRAD Price
(Digirad Corporation stock price per share)
$0.64
[?] PE Ratio versus Sector 26% lower than other Healthcare stocks
[?] PE Ratio versus Industry 671% higher than other Medical Devices stocks
[?] Free Cash Flow Jitter 250%
[?] Dividend Yield 24%

Is Digirad Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy Digirad Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy DRAD Stock?

Does Digirad Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.